Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 7
Author(s): Craig S. Atwood
Affiliation:
Export Options
About this article
Cite this article as:
Atwood S. Craig, Meet Our Editorial Board Member, Current Neuropharmacology 2019; 17 (7) . https://dx.doi.org/10.2174/1570159X1707190521092957
DOI https://dx.doi.org/10.2174/1570159X1707190521092957 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment
CNS & Neurological Disorders - Drug Targets Characterization of Single Nucleotide Polymorphisms of Cytochrome P450 in an Australian Deceased Sample
Current Drug Metabolism MMP-9, a Potential Target for Cerebral Ischemic Treatment
Current Neuropharmacology Experimental Brain Ischemic Preconditioning: A Concept to Putative Targets
CNS & Neurological Disorders - Drug Targets Sex Hormones and Brain Dopamine Functions
Central Nervous System Agents in Medicinal Chemistry The Emerging Role of the Endocannabinoid System in the Sleep-Wake Cycle Modulation
Central Nervous System Agents in Medicinal Chemistry Mechanisms of Adeno-Associated Virus Genome Encapsidation
Current Gene Therapy Editorial [Hot Topic: Frontiers of Metabolomics – Going from Bench to Bedside (Guest Editor: Anders Nordstrom)]
Current Pharmaceutical Biotechnology Pyrazoline: A Promising Scaffold for the Inhibition of Monoamine Oxidase
Central Nervous System Agents in Medicinal Chemistry Proteins Commonly Linked to Autism Spectrum Disorder and Alzheimer's Disease
Current Protein & Peptide Science Immune Responses to AAV in Clinical Trials
Current Gene Therapy Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease
Current Medicinal Chemistry Bacteriocins Active Against Multi-Resistant Gram Negative Bacteria Implicated in Nosocomial Infections
Infectious Disorders - Drug Targets Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study
CNS & Neurological Disorders - Drug Targets Editorial [Hot topic:VIP and PACAP: Novel Approaches to Brain Functions and Neuroprotection (Executive Guest Editors: Seiji Shioda and Illana Gozes)]
Current Pharmaceutical Design Synthesis, Molecular Docking and Anticancer Evaluation of New Arylazothiazoles
Current Organic Synthesis The Role of Nuclear Medicine in Vascular Dementia
Vascular Disease Prevention (Discontinued) Novel Pharmacologic Approaches to the Management of Sepsis: Targeting the Host Inflammatory Response
Recent Patents on Inflammation & Allergy Drug Discovery Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Current Pharmaceutical Design New Electrocardiographic Features in Brugada Syndrome
Current Cardiology Reviews